Scarica l'app Stockscreener
0.91
1.09%
-0.01
Precedente Chiudi:
$0.92
Aprire:
$0.95
Volume 24 ore:
1,908
Relative Volume:
0.02
Capitalizzazione di mercato:
$1.74M
Reddito:
$90,700
Utile/perdita netta:
$-3.43M
Rapporto P/E:
-0.5594
EPS:
-1.6266
Flusso di cassa netto:
$-4.65M
1 W Prestazione:
-4.21%
1M Prestazione:
-14.95%
6M Prestazione:
-72.83%
1 anno Prestazione:
-87.66%
Intervallo 1D:
$0.91
$0.95
Intervallo di 1 settimana:
$0.86
$0.98
Portata 52W:
$0.7015
$18.36
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Nome
60 Degrees Pharmaceuticals Inc
Settore
Industria
Telefono
202-327-5422
Indirizzo
1025 CONNECTICUT AVENUE NW, WASHINGTON
Confronta SXTP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| SXTP | 0.91 | 1.74M | 90,700 | -3.43M | -4.65M | -1.6266 |
| VRTX | 446.78 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 738.30 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 586.52 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.35 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.55 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
60 Degrees Pharmaceuticals Inc Borsa (SXTP) Ultime notizie
60 Degrees Pharmaceuticals’ (SXTP) Neutral Rating Reaffirmed at HC Wainwright - Defense World
60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue Estimates - MSN
60 Degrees Pharmaceuticals Reports 164% Sales Surge in Q3 2024, Driven by ARAKODA® Growth - GuruFocus.com
60 Degrees Pharmaceuticals Inc. Warrant (SXTPW) Quarterly 10-Q Report - Quartz
ARMISTICE CAPITAL, LLC Acquires New Stake in 60 Degrees Pharmace - GuruFocus.com
HALO Stock Dips 5.77% Amid Biotech Sector Changes - GuruFocus.com
60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results - GlobeNewswire
60 Degrees Pharma Reports 164% Revenue Surge, Doubles ARAKODA® Deliveries in Q3 | SXTP Stock News - StockTitan
OptiNose (OPTN) Reports Break-Even Earnings for Q3 - Nasdaq
60 Degrees Pharmaceuticals secures shareholder nods for key proposals - Investing.com India
60 Degrees Pharmaceuticals secures shareholder nods for key proposals By Investing.com - Investing.com South Africa
Recursion Pharmaceuticals (RXRX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Compugen (CGEN) Stock Surges Amidst Biotech Sector Volatility - GuruFocus.com
TNF Pharmaceuticals (NASDAQ:TNFA) Stock Quotes, Forecast and News Summary - Benzinga
SEC Form DEF 14A filed by 60 Degrees Pharmaceuticals Inc. - Quantisnow
Allovir (ALVR) Stock Experiences Significant Decline Amid Negati - GuruFocus.com
Why Is Infection Treatment Focused-60 Degrees Pharmaceuticals Stock Soaring Today? - MSN
SXTP stock plunges to 52-week low, touches $1 mark By Investing.com - Investing.com UK
Why Are 60 Degrees Pharmaceuticals Shares Up By 50% Today? - MSN
60 Degrees Pharmaceuticals Outlines Plans For Rare Tick-Borne Infection Trial Evaluating Its Malaria Drug - MSN
60 Degrees Pharmaceuticals launches Arakoda promotional pilot - TipRanks
60 Degrees Pharmaceuticals pilots ARAKODA awareness program By Investing.com - Investing.com South Africa
60 Degrees Pharmaceuticals pilots ARAKODA awareness program - Investing.com
SXTP stock plunges to 52-week low, touches 1.01 USD By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch - The Manila Times
Del Taco Leads the Value Pack with New Del's Mucho Meal$™ and the Return of Cookie Butter Shake! - The Manila Times
Form PRE 14A 60 DEGREES PHARMACEUTICA For: Oct 02 - StreetInsider.com
K-pop group Fifty Fifty off to strong start with member line-up reboot - The Straits Times
Documented Gang Member Sentenced to Life in Prison for Killing Five People - Harris County District Attorney's Office
Ultraviolette set to export F77 sports bikes to European countries - Business Upturn
Tectonic Therapeutic reports findings from Phase Ia trial of TX45 - Clinical Trials Arena
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 - EIN News
Market Trading Guide: Century Textiles, Jubilant Foodworks among 5 stock recommendations for Friday - The Economic Times
Heavy Buying Alert: Multibagger IT-stock Hits Upper Circuits On September 18; Zooms 69 Per Cent From 52-Week Low! - Dalal Street Investment Journal
100 films to be made in 48 hours - IOL
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Rating Reiterated by HC Wainwright - Defense World
Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying - Benzinga
60 degrees pharmaceuticals director buys $8,500 in stock By Investing.com - Investing.com Canada
60 degrees pharmaceuticals director buys $8,500 in stock - Investing.com India
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Trading Down 3.1% - Defense World
SXTPW60 Degrees Pharmaceuticals, Inc. Warrant Latest Stock News & Market Updates - StockTitan
60 Degrees Pharmaceuticals Announces Closing of $4 Million Private Placement - citybiz
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 - GlobeNewswire
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - Yahoo Finance
60 Degrees Pharmaceuticals to raise $4M via private placement; shares fall - MSN
60 Degrees Pharmaceuticals announces private placement sale - Investing.com India
60 Degrees Pharmaceuticals to sell 2.9M shares at $1.38 in private placement - TipRanks
60 Degrees Pharmaceuticals announces private placement sale By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
60 Degrees Pharmaceuticals Inc (SXTP)’s Day in Review: Closing at 1.34, Down by -11.84 - The Dwinnex
60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements - GlobeNewswire
60 Degrees Pharmaceuticals Inc Azioni (SXTP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
60 Degrees Pharmaceuticals Inc Azioni (SXTP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
May 16 '24 |
Option Exercise |
0.22 |
2,000 |
446 |
228,934 |
| FIELD PAUL | Director |
May 16 '24 |
Option Exercise |
0.22 |
4,000 |
892 |
14,000 |
| DOW GEOFFREY S | President and CEO |
Apr 12 '24 |
Option Exercise |
0.27 |
68,000 |
18,142 |
745,625 |
| DOW GEOFFREY S | President and CEO |
May 16 '24 |
Option Exercise |
0.22 |
17,000 |
3,791 |
762,625 |
| Allen Charles W | Director |
May 16 '24 |
Option Exercise |
0.22 |
4,000 |
892 |
14,000 |
| DOW GEOFFREY S | President and CEO |
Jan 31 '24 |
Buy |
0.38 |
25,974 |
9,740 |
703,599 |
| XU CHERYL | Director |
Jan 31 '24 |
Buy |
0.38 |
200,000 |
75,000 |
424,934 |
0.42%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):